Hope in the TB Pipeline: Vaccines Dr. Michael Brennan Senior Advisor, Global Affairs J2J Lung Health Media Training 42nd Union World Conference on Lung Health Lille, France…

1.Today’s Gadgets & Emerging Technology Innovations Wednesday, June 18, 2014 Mark Goldstein, International Research Center PO Box 825, Tempe, AZ 85280-0825, Phone:…

Slide 1 TUBERCOLOSIS Agis Terzidis, Paediatrician Spyridon Gialamas, Medical Doctor SEMINAR ON TROPICAL AND TRAVEL MEDICINE AT TTCIH IFAKARA 25 JUNE 2009 Slide 2 Estimated…

Slide 1 T reatment A ction G roup Update on Global TB Research By Claire Wingfield Treatment Action Group Advisory Council for the Elimination of Tuberculosis Centers for…

Summary Chapter 6.8: Tuberculosis Chapter 6.8: Tuberculosis Priority Medicines for Europe and the World "A Public Health Approach to Innovation" Background Paper…

Tuberculosis R&D Investments: A Preliminary Assessment by Cindra Feuer edited by Javid Syed and Mark Harrington with Bob Huff August 2006 Table of Contents Foreword Executive…

MARCH 2011 TREATMENT ACTION GROUP BY ELEONORA JIMÃNEZ SALAZAR TUBERCULOSIS RESEARCH & DEVELOPMENT: 2010 Report on Tuberculosis Research Funding Trends, 2005â2009 2nd…

1 second printing MAY 2009 bY NEHA AGARWAL EditEd bY JAVid SYEd & MARk HARRiNGtoN tubERcuLoSiS RESEARcH & dEVELopMENt: A critical Analysis of Funding trends, 2005â2007:…

The way forward for TB vaccines Tuberculosis (TB) is now the largest single-pathogen cause of global adult mortality 1; more than 10 million incident cases of disease occur